Key growth factor protects gut from inflammatory bowel disease

Posted on by ContraReport

In their study, published Jan. 31 in Nature Immunology, the researchers found that the growth factor, HB-EGF, is produced in response to gut inflammation by a set of immune-regulating cells called ILC3s. These immune cells reside in many organs including the intestines, though their numbers are known to be depleted in the inflamed intestines of IBD patients.

Read press release from medXpress.
Read paper published in Nature Immunology: DOI: 10.1038/s41590-021-01110-0

Related Posts

Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? (2011)

“Cannabinoids can modulate both the function and secretion of cytokines from immune cells. Therefore, cannabinoids may be considered for treatment of inflammatory disease.” Kozela, E., Lev, N., Kaushansky, N., Eilam, […]

The serotonin theory of depression: a systematic umbrella review of the evidence

“The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by […]

New evidence that mindfulness meditation reduces stress by altering brain connectivity

“Mindfulness meditation reduces stress by increasing brain connectivity between top-down executive control regions, according to a recent study published this July in Biological Psychiatry.”